- Home
- AXS vs ICLR Comparison
AXS vs ICLR Comparison
Compare AXS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXS | ICLR |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | Bermuda | Ireland |
| Employees | 1876 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.1B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | AXS | ICLR |
|---|---|---|
| Price | $104.31 | $108.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | $121.86 | ★ $194.38 |
| AVG Volume (30 Days) | 622.0K | ★ 3.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.36 | N/A |
| Revenue Next Year | $6.20 | N/A |
| P/E Ratio | ★ $8.43 | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $84.81 | $66.57 |
| 52 Week High | $110.34 | $211.00 |
Technical Indicators
Market Signals| Indicator | AXS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 36.51 |
| Support Level | $98.76 | $66.57 |
| Resistance Level | $108.57 | $189.62 |
| Average True Range (ATR) | 2.66 | 8.09 |
| MACD | 0.21 | 2.12 |
| Stochastic Oscillator | 62.61 | 53.35 |
Price Performance
Historical ComparisonAbout AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.